If you could vote on Brexit now which option would you choose?
   

From Oxford to an Italian lab, one race for coronavirus vaccine is gaining backers


Oxford manufactured its own vaccine for use in the earliest small trial known as Phase 1. But for the far larger ongoing trials — involving tens of thousands of people — it turned to Advent, a division of a larger group known as IRBM, which for a decade has focused on making one particular type of experimental vaccines, using adenoviruses. The notion of having a vaccine so quickly — when the process of experimentation and approval normally takes a decade — might have seemed fanciful at the beginning of the outbreak. But given the scale of the pandemic and the speed at which scientists are racing ahead, European countries are lining up behind the Oxford University project, saying the early signals give grounds for optimism.

Washington Post - June 20, 2020

View the full story here: https://www.washingtonpost.com/world/europe/vaccine-coronavirus-oxford-italy-trials/2020/06/20/4b8f5e0a-af1c-11ea-98b5-279a6479a1e4_story.html?utm_campaign=wp_todays_worldview&utm_medium=email&utm_source=newsletter&wpisrc=nl_todayworld